Bionano genomics announces the kick-off of its next-generation cytogenomics symposium, the largest event yet to showcase saphyr's utility in genome analysis for genetic disease and cancer

San diego, jan. 10, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) announced the kick-off its 5-day next-generation cytogenomics symposium, which starts monday january 11 and will feature 33 presentations by distinguished saphyr users from leading hospitals and medical research institutions around the world. the presentations will cover applications of optical genome mapping (ogm) with saphyr to analyze the genomes of patients with a variety of genetic diseases, blood cancers, solid tumors and repeat disorders as well as the studies supporting validation of clinical assays developed by saphyr users. the last day of the symposium is dedicated to the study of the genomes of severely ill covid-19 patients. the event is being held virtually and concludes on january 15, 2021.
BNGO Ratings Summary
BNGO Quant Ranking